| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |